Table 1 Demographics and characteristics of the study group
From: Treatment persistence of biologics among patients with psoriatic arthritis
Patients’ characteristics | N = 2301 | ||
|---|---|---|---|
Age | 50.9 ± 14 years | ||
Sex | Male | 429 | 46.1% |
Female | 502 | 53.9% | |
SES | Unknown | 6 | 0.7% |
Low | 275 | 30.8% | |
Medium | 365 | 40.8% | |
High | 248 | 27.7% | |
Ethnicity | Arab | 120 | 13.4% |
Jewish | 774 | 86.6% | |
BMI | 0–18.5 | 21 | 2.3% |
18.5–25 | 249 | 27.3% | |
25–30 | 304 | 33.4% | |
30+ | 337 | 37.0% | |
Obesity | No | 589 | 63.3% |
Yes | 342 | 36.7% | |
Smoking status | No | 557 | 59.9% |
Yes | 373 | 40.1% | |
Charlson comorbidity index | 0 | 227 | 24.4% |
1 | 372 | 40.0% | |
2 | 148 | 15.9% | |
3 | 103 | 11.1% | |
4+ | 80 | 8.6% | |